LIVE EVENT
GCN Investor Conference in Newport Beach, CA
OCT 15 · NEWPORT BEACH, CA
LIVE EVENT
GCN Investor Conference in Newport Beach, CA
OCT 15 · NEWPORT BEACH, CA
Register →
Search
← Research archive
2023
Retrospective
Asia-Pacific
Venture Capital

India Venture Capital Report 2023 — The Funding Winter That Wasn't Uniform

India's 2023 contraction was widely reported as a funding winter. The more accurate description is a change in what gets funded — and the businesses that struggled were largely those whose models the market had already been questioning.

At a glance
  • The contraction was sharpest where foreign capital had been most concentrated, which is a statement about funding sources rather than about Indian conditions.
  • Domestic capital grew as a share of funding, which is the year's most durable structural development.
  • The businesses that struggled were largely those the 2017 income arithmetic had always constrained, brought forward by the removal of subsidy capital.
  • Profitability became the dividing line, making India's bifurcation axis different from the US's.
  • The domestic listing route stayed open, which is what distinguished India's contraction from previous ones.

Executive summary

Indian venture funding fell substantially in 2023 from its 2021 peak. The contraction was widely described as a funding winter, which is accurate about the magnitude and misleading about the cause.

The contraction was primarily a withdrawal of foreign capital, and the reasons were largely external. As the 2021 report describes, a substantial share of the 2021 surge had come from capital reallocating within Asia and from the globally abundant conditions of that year. When those conditions reversed — rates rose, global venture contracted, and LP liquidity constrained commitment pacing — the capital that had arrived for reasons elsewhere left for reasons elsewhere.

Indian conditions had not deteriorated correspondingly. Growth continued, the domestic economy performed reasonably, and the structural case the 2023 Asia-Pacific report describes remained intact.

The distinction matters because it determines what recovers and when. A contraction caused by deteriorating local conditions recovers when those conditions improve. One caused by the withdrawal of foreign capital recovers when conditions elsewhere improve — which is outside anyone's local control.

The year's most durable development was the growth of domestic capital. Indian institutional investors, family offices and corporate investors became a larger share of funding. That reduces the sensitivity described above, and it is the single most important structural improvement in the market.

The businesses that struggled were largely predictable, and the 2017 report describes why. Models requiring high revenue per user, or funded by discounting, faced the test that abundance had deferred. The removal of subsidy capital did not create the problem; it brought forward the point at which it became visible.

What distinguished 2023 from previous Indian contractions was that the exit route stayed open. Domestic listing remained available, which meant companies with genuine businesses had a path.

Where the capital went and why

Tracing the withdrawal precisely matters, because it determines what the contraction was actually measuring.

The 2021 surge had three components, per the 2021 report:

  • Global abundance. The conditions the 2021 global report describes — near-zero rates, abundant capital, competition for access.
  • Regional reallocation. Capital reducing exposure to another regional market and seeking Asian growth elsewhere.
  • Genuine structural interest in the Indian market on its own merits.

The first two reversed and the third did not.

Global abundance ended for the reasons the 2022 reports describe. Regional reallocation stabilised as the initial repositioning completed. Structural interest persisted, and Indian allocations remained above their pre-2021 levels.

The consequence is that the contraction from the 2021 peak overstates the deterioration, because the peak itself was inflated by two temporary components. The more informative comparison is against 2019 or 2020 rather than against 2021 — and on that comparison, Indian funding remained substantially higher.

The general point is one worth applying to any market that experienced a 2021 surge: measuring a contraction from a peak that was itself anomalous overstates it. The relevant baseline is the pre-surge trend, not the surge.

This is the same error, in the opposite direction, as the pull-forward mistake the 2020 US venture report describes — extrapolating from the steepest part of a curve. In both cases the error is choosing the anomalous period as the reference.

Domestic capital as the structural improvement

The growth of domestic capital is the year's most consequential development and deserves treatment on its own terms.

The sources that grew:

  • Domestic institutional investors — insurers, pension vehicles and mutual funds — with growing allocations to alternatives.
  • Family offices, reflecting accumulated domestic wealth.
  • Corporate venture arms of Indian companies.
  • Domestic funds raising from domestic LPs rather than principally from abroad.

Why this matters more than the amount suggests:

  • Stability. Domestic capital has local liabilities and is less likely to withdraw during a global risk-off episode. This directly addresses the vulnerability the contraction exposed.
  • Different preferences. Domestic capital frequently favours businesses serving domestic markets, where local knowledge is an advantage — which supports categories that foreign capital, applying imported frameworks, systematically underweighted.
  • Different time horizons. Family office and corporate capital may have longer horizons than fund structures permit.
  • Governance familiarity. Domestic investors understand the regulatory and commercial environment without a learning cost.

The connection to the exit route matters and is worth making explicit. As the 2021 report describes, domestic listing brought Indian institutional investors into venture-backed companies as public shareholders. That familiarity supports their participation as private investors — the public and private markets develop together, and the exit route opening is part of what enabled the domestic capital growth.

For foreign investors the competitive implication is the one the 2025 Asia-Pacific report generalises: capital alone is no longer a differentiated offer. Participation increasingly requires something else — cross-border expertise, access to international markets, or specialist sector knowledge.

The deferred test arrives

The businesses that struggled in 2023 were largely those the 2017 report identifies as structurally constrained, and the mechanism is worth stating because it is the clearest available illustration.

The 2017 analysis: models requiring high revenue per user face an arithmetic bound in a market where the addressable segment for that spending is small. Discount-funded growth measures price sensitivity rather than demand. Metrics measured under subsidy describe the subsidised state.

What capital abundance did: it allowed businesses to fund losses for longer, deferring the point at which the constraint became visible. A business burning capital to subsidise transactions can continue as long as capital is available.

What the contraction did: it removed the deferral. Businesses that could not raise had to reach profitability with what they had, which required ending subsidies, which revealed what the subsidies had been purchasing.

The results separated cleanly, as the 2017 report anticipates:

  • Where the subsidy had accelerated adoption of a valued service, customers largely stayed. Revenue fell as discounts ended, then stabilised and grew from a lower base. These businesses survived.
  • Where the subsidy was the value proposition, customers left. Revenue fell and kept falling. These businesses shut, sold, or restructured.

Capital abundance defers the test of a business model. It does not change the answer. The contraction did not create the problem — it removed the funding that had been concealing it.

The general observation, which recurs throughout this archive: a period of easy capital does not fix weak business models; it postpones the discovery. The 2019 US venture report describes the same pattern at the level of an entire market, and the 2023 US venture report describes the deferrals expiring globally.

Profitability as the dividing line

India's bifurcation in 2023 ran along a different axis than the US's, and the difference is diagnostic in the sense the 2025 Asia-Pacific report describes.

In the US, the axis was artificial intelligence. Thematic exposure determined capital availability.

In India, the axis was profitability. Companies with demonstrated unit economics could raise; companies without could not, largely regardless of sector.

What that reveals: Indian capital in 2023 was selecting for capital efficiency rather than for thematic exposure. That is a market disciplined by an experience of subsidy-funded growth failing, underwriting to cash generation rather than to a future sale.

The consequences:

  • Dispersion was lower than in a thematically-bifurcated market, since profitability is more evenly distributed across sectors than any theme.
  • The businesses funded were more durable, since profitability is a harder test than thematic relevance.
  • Returns were likely lower and safer. A market underwriting to demonstrated economics produces fewer very large outcomes and fewer failures.
  • B2B and financial services benefited, being categories where the income constraint binds less and unit economics are clearer earlier.

This is the healthier configuration, per the 2025 Asia-Pacific report's framework, and it is less exciting. A market that has learned to underwrite to profitability has learned something durable — and the learning came at the cost of the 2021 vintage.

Choosing the right baseline

The claim that measuring from the 2021 peak overstates the contraction is a general point about cyclical measurement, and it is worth setting out because the error is made routinely in both directions.

The problem. A measurement is a comparison, and a comparison requires a reference point. Choosing an anomalous period as the reference produces a result that describes the anomaly rather than the change.

The two symmetric errors:

  • Measuring from a peak overstates a decline. If the peak was inflated by temporary factors, the fall from it includes the removal of those factors as well as any genuine deterioration.
  • Measuring from a trough overstates a recovery. The same logic in reverse, and it produces the "record growth" headlines that follow every contraction.

The 2020 US venture report describes a third version of the same error: annualising from the steepest part of an adoption curve. In each case the mistake is selecting the least representative point as the reference.

How to choose a better baseline:

  • Identify the pre-anomaly trend. If funding grew at a consistent rate through 2017–2019, that trend line is the reference, and the question is where the current level sits relative to it.
  • Decompose the anomalous period. The 2021 Indian surge had three components — global abundance, regional reallocation, and genuine structural interest. Two reversed and one did not. Knowing which components were temporary tells you what the sustainable level is.
  • Use multiple reference points. Comparing to 2021, to 2019, and to the pre-2021 trend gives three answers, and the divergence between them is itself informative.
  • Prefer count to value where possible. Deal count is less affected by a few very large rounds and therefore less distorted by a concentrated surge.

A contraction measured from an inflated peak is partly the deflation of the inflation. That is a real thing to describe and it is not the same as deterioration, and the two are routinely reported as one.

What an allocator could act on

Attribute a contraction to its cause before drawing conclusions. A contraction caused by deteriorating local conditions recovers when those improve. One caused by foreign capital withdrawal recovers when conditions elsewhere improve — which is outside anyone's local control. The distinction determines what recovers and when, and the two look identical in funding totals.

Track domestic capital share as the stability indicator. Domestic capital has local liabilities and is less likely to withdraw during a global risk-off episode. SEBI publishes free quarterly data on alternative investment fund commitments, which distinguishes domestic activity from foreign flows in a way commercial providers do not.

Recognise that abundance defers a business model test rather than answering it. Businesses whose models required customers to spend more than the addressable segment could afford did not become viable through longer runway. The contraction did not create the problem — it removed the funding that had been concealing it, which is why the outcomes separated so cleanly.

Read the bifurcation axis as diagnostic. India bifurcated on profitability rather than on theme, which indicates a market underwriting to cash generation rather than to a future sale. That produces lower dispersion, more durable businesses, and lower and safer returns. It is the healthier configuration and it is less exciting, and it was learned at the cost of the 2021 vintage.

Note that the public and private markets developed together. Domestic listing brought Indian institutions into venture-backed companies as public shareholders, and that familiarity supported their participation as private investors. The exit route opening is part of what enabled the domestic capital growth, which means the two developments reinforce rather than merely coincide.

What 2023 established for India

  • The contraction measured foreign capital withdrawal, not deteriorating Indian conditions.
  • Measuring from an anomalous peak overstates a contraction — the pre-surge trend is the correct baseline.
  • Domestic capital growth is the durable improvement, and it developed alongside the domestic exit route.
  • Capital abundance defers business model tests rather than changing their answers.
  • Profitability as the bifurcation axis indicates a market underwriting to cash generation — the healthier and less exciting configuration.

Methodology & data vintage

Methodology and data vintage

A structural retrospective on Indian venture capital in 2023, focused on what the contraction was actually measuring and what the year changed structurally.

Where figures appear they carry a numbered source. Mechanisms — capital source and contraction attribution, baseline selection in cyclical measurement, domestic capital stability, deferred business model tests, bifurcation axis as diagnostic — are analysis with reasoning shown.

This report follows the 2017 and 2021 India reports and is the country companion to the 2023 Asia-Pacific report.

Risks and caveats to this analysis

  • Retrospective and recent, written from mid-2026.
  • The foreign-versus-domestic capital split is directionally supported but imprecisely measured, since investor composition is not systematically reported.
  • The "deferred test" framing is a generalisation. Individual company outcomes reflected many factors, and no assessment of any company is expressed.
  • The bifurcation axis characterisation is a judgement, not a measured finding.
  • The income constraint discussion generalises across a market with very wide internal income dispersion.
  • Scope is Indian venture capital.

Sources

India Venture Capital Report 2017 sets out the income arithmetic whose test this report describes arriving — why models requiring high revenue per user face an arithmetic bound, why any metric measured under subsidy describes the subsidised state, and why the addressable market is set by spending capacity rather than population.

India Venture Capital Report 2021 describes the surge this report measures the contraction from, including the three components of that surge — global abundance, regional reallocation and genuine structural interest — of which two reversed. It also describes the opening of the domestic listing route that kept this contraction from resembling previous ones.

India Venture Capital Outlook 2026 closes the sequence, separating the allocation question from the entry price question and scoring the whole four-part arc.

For the global context, the US Venture Capital Report 2023 describes the same year from the perspective of the market whose capital withdrawal drove India's contraction — the LP liquidity chain binding, deferrals expiring, and the measurement gap in downturn data.

For the regional context, the Asia-Pacific Investment Report 2023 describes institutions unbundling regional allocations, with India becoming a standalone position for many of them, and the 2025 regional report develops the bifurcation-axis framework this report applies.

On the deferred-test mechanism — that capital abundance postpones the discovery of a weak business model rather than changing the answer — the fullest treatments are the Global Investment Outlook 2019 on interrupted corrections and the US Venture Capital Report 2023 on deferrals expiring.

Global Capital Network

Get research like this before it is public

Accredited investors receive our market reports, private event invitations and curated deal flow.

Register as an investor
CONNECTING INVESTORS & FOUNDERS
NETWORK VISION
Our vision and the strength of our global network
INVESTOR NETWORK
Connect with a curated community of investors
PITCH OPPORTUNITIES
Get your deal in front of our investors
INVESTOR EVENTS
Engage in exclusive investor events.
RESOURCES
Stay informed with insights and updates.
DEAL FLOW
Join our digital platform and get connected
Powered by 2030VENTURES